Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy

Brain

Volumn 136, Issue 9, 2013, Pages 2876-2887

  Ando, Hitoshi ^a   Sato, Tomoo ^a   Tomaru, Utano ^b   Yoshida, Mari ^c   Utsunomiya, Atae ^d   Yamauchi, Junji ^a   Araya, Natsumi ^a   Yagishita, Naoko ^a   Coler Reilly, Ariella ^a   Shimizu, Yukiko ^a   Yudoh, Kazuo ^a   Hasegawa, Yasuhiro ^a   Nishioka, Kusuki ^e   Nakajima, Toshihiro ^e   Jacobson, Steven ^f   Yamano, Yoshihisa ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d IMAMURA BUN IN HOSPITAL   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

astrocyte; CXCL10; CXCR3; HAM TSP; HTLV 1

Indexed keywords

CARBON TETRACHLORIDE; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; NEUTRALIZING ANTIBODY; RANTES; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID CYTOLOGY; CHEMOTAXIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD DISEASE; SPINAL CORD LESION; STAINING; TH1 CELL; THORACIC SPINAL CORD; TROPICAL SPASTIC PARAPARESIS;

EID: 84883360793     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt183     Document Type: Article

References (55)

1. Furuya T, Nakamura T, Shirabe S, Nishiura Y, Tsujino A, Goto H, et al. Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy. Proc Assoc Am Physicians 1997; 109: 228-36.
2. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407-10.
3. Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP, et al. High frequencies of Th1-type CD4( + ) T cells specific to HTLV-1 env and tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 2002; 99: 3335-41.
4. Groom JR, Richmond J, Murooka TT, Sorensen EW, Sung JH, Bankert K, et al. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4( + ) T helper 1 cell differentiation. Immunity 2012; 37: 1091-103.
5. Hanon E, Goon P, Taylor GP, Hasegawa H, Tanaka Y, Weber JN, et al. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood 2001; 98: 721-6.
6. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-80.
7. Ijichi S, Eiraku N, Osame M, Izumo S, Kubota R, Maruyama I, et al. In vitro modulation of lymphocyte proliferation by prednisolone and interferon-alpha in patients with HTLV-I-associated myelopathy (HAM). J Neuroimmunol 1989; 23: 175-8.
8. Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003; 9: 3625-34.
9. Itoyama Y, Minato S, Kira J, Goto I, Sato H, Okochi K, et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 1988; 38: 1302-7.
10. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990; 96: 103-23.
11. Izumo S, Ijichi T, Higuchi I, Tashiro A, Takahashi K, Osame M. Neuropathology of HTLV-I-associated myelopathy-a report of two autopsy cases. Acta Paediatr Jpn 1992; 34: 358-64.
12. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8(plus) cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348: 245-8.
13. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999; 96: 3848-53.
14. Kirkham BW, Lassere MN, Edmonds JP, Juhasz KM, Bird PA, Lee CS, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 2006; 54: 1122-31.
15. Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S. HTLV-I specific IFN-gamma + CD8 + lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J Neuroimmunol 2000; 102: 208-15.
16. Lee EY, Lee ZH, Song YW. CXCL10 and autoimmune diseases. Autoimmun Rev 2009; 8: 379-83.
17. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
18. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-45.
19. Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987; 166: 1084-97.
20. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-44.
21. Matsuoka E, Takenouchi N, Hashimoto K, Kashio N, Moritoyo T, Higuchi I, et al. Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization. Acta Neuropathol 1998; 96: 340-6.
22. Matsuura E, Yamano Y, Jacobson S. Neuroimmunity of HTLV-I infection. J Neuroimmune Pharmacol 2010; 5: 310-25.
23. Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999; 5: 101-4.
24. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010; 140: 771-6.
25. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-35.
26. Moritoyo H, Arimura K, Arimura Y, Tokimura Y, Rosales R, Osame M. Study of lower limb somatosensory evoked potentials in 96 cases of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci 1996; 138: 78-81.
27. Muller M, Carter S, Hofer MJ, Campbell IL. Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity-a tale of conflict and conundrum. Neuropathol Appl Neurobiol 2010; 36: 368-87.
28. Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S. Increased HTLV-I proviral load and preferential expansion of HTLV-I tax-specific CD8 + T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 2001a; 50: 807-12.
29. Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S. CD8( + ) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 2001b; 98: 1858-61.
30. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4: 586-93.
31. Narikawa K, Fujihara K, Misu T, Feng J, Fujimori J, Nakashima I, et al. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha. J Neuroimmunol 2005; 159: 177-82.
32. Nie CQ, Bernard NJ, Norman MU, Amante FH, Lundie RJ, Crabb BS, et al. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog 2009; 5: e1000369.
33. Osame M. Review of WHO kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner WA, editor. Human retrovirology: HTLV. New York: Raven Press, 1990. p. 191-7.
34. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031-2.
35. Proost P, Vynckier AK, Mahieu F, Put W, Grillet B, Struyf S, et al. Microbial toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Eur J Immunol 2003; 33: 3146-53.
36. Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, et al. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 2001; 98: 3554-61.
37. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746-54.
38. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008; 89: 1-47.
39. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990; 64: 5682-7.
40. Saito M, Bangham CR. Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives. Leuk Res Treatment 2012; 2012: 259045.
41. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-83.
42. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the lymphoma study group (1984-87). Br J Haematol 1991; 79: 428-37.
43. Sung JH, Zhang H, Moseman EA, Alvarez D, Iannacone M, Henrickson SE, et al. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 2012; 150: 1249-63.
44. Tanaka M, Matsushita T, Tateishi T, Ochi H, Kawano Y, Mei FJ, et al. Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 2008; 71: 974-81.
45. Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, McNab FW, et al. Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog 2012; 8: e1002480.
46. Teixeira AL Jr, Cardoso F, Souza AL, Teixeira MM. Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in sydenham's chorea patients. J Neuroimmunol 2004; 150: 157-62.
47. Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 2003; 171: 2571-80.
48. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1994; 53: 72-7.
49. Van den Steen PE, Deroost K, Van Aelst I, Geurts N, Martens E, Struyf S, et al. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur J Immunol 2008; 38: 1082-95.
50. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006; 6: 595-601.
51. Yamano Y, Sato T. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Front Microbiol 2012; 3: 389.
52. Yamano Y, Takenouchi N, Li HC, Tomaru U, Yao K, Grant CW, et al. Virus-induced dysfunction of CD4 + CD25 + T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 2005; 115: 1361-8.
53. Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, et al. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8( + ) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002; 99: 88-94.
54. Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D, et al. Abnormally high levels of virus-infected IFN-gamma + CCR4 + CD4 + CD25 + T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One 2009; 4: e6517.
55. Yasuda N, Lai PK, Ip SH, Kung PC, Hinuma Y, Matsuoka M, et al. Soluble interleukin 2 receptors in sera of japanese patients with adult T cell leukemia mark activity of disease. Blood 1988; 71: 1021-6.